- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02645773
Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring
February 8, 2016 updated by: Katrine Elisabeth Karmisholt, Bispebjerg Hospital
To investigate intervention with early application of non-ablative laser to prevent scarring in the skin
Study Overview
Detailed Description
To intervene in scar formation at three different time-points
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark
- Bispebjerg Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- good health
- men
- Skin type 2-3
- non-smokers
- presenting full medical record
Exclusion Criteria:
- active skin disease in test area
- resent UV-exposure in test area
- history of keloid
- current or resent cancer
- uncontrolled systemical disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pre-laser
non-ablative laser Laser Pre-wounding low dose laser Pre-wounding medium dose laser Pre-wounding high dose
|
non-abaltive laser pre, immediate and post wounding
Other Names:
|
Experimental: Immediate-laser
non-ablative laser Laser low dose - immediate after wounding Laser medium dose - immediate after wounding Laser high dose - immediate after wounding
|
non-abaltive laser pre, immediate and post wounding
Other Names:
|
Experimental: Post-laser
non-ablative laser Laser low dose - post wounding Laser medium dose - post wounding Laser medium dose - post wounding
|
non-abaltive laser pre, immediate and post wounding
Other Names:
|
No Intervention: Control
Untreated control wound
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To measure the clinical effect on scarring of non-ablative laser intervention at the three time-points
Time Frame: 3 months after
|
Clinical evaluation by scar scales
|
3 months after
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
December 30, 2015
First Submitted That Met QC Criteria
December 31, 2015
First Posted (Estimate)
January 5, 2016
Study Record Updates
Last Update Posted (Estimate)
February 9, 2016
Last Update Submitted That Met QC Criteria
February 8, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Early intevention
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cicatrix
-
Samsung Medical CenterSeoul National University Hospital; Kyunghee University Medical Center; InovailUnknownHypertrophic CicatrixKorea, Republic of
-
Olix Pharmaceuticals, Inc.CompletedCicatrix, HypertrophicUnited Kingdom
-
HugelCompletedHypertrophic ScarKorea, Republic of
-
SolitonUnited States Naval Medical Center, San DiegoNot yet recruitingScars, Hypertrophic
-
Seton Healthcare FamilyCompleted
-
Hospital Universitari Vall d'Hebron Research InstituteCompletedCicatrix, HypertrophicSpain
-
Nova Scotia Health AuthorityRecruiting
-
Henry Ford Health SystemActive, not recruitingScar | Hypertrophic ScarUnited States
-
Massachusetts General HospitalWithdrawnHypertrophic ScarsUnited States
-
University of California, Los AngelesWithdrawnCosmetics, Suture, CicatrixUnited States
Clinical Trials on non-ablative laser
-
Bispebjerg HospitalCompleted
-
The Cleveland ClinicTerminatedAbdominoplasty ScarsUnited States
-
Massachusetts General HospitalUnknown
-
Montefiore Medical CenterScitonRecruitingAndrogenetic Alopecia | Scarring AlopeciaUnited States
-
King's College Hospital NHS TrustAlexandra Hospital, Athens, GreeceCompleted
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Hangang Sacred Heart HospitalNational Research Foundation of KoreaNot yet recruitingStem Cell Media | Hypertrophic Scar | Regeneration
-
Thaís Hofmann CachafeiroUnknown
-
Lumenis Be Ltd.Active, not recruiting
-
Adrian GasparFotona d.o.o.CompletedStress Urinary Incontinence